Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Verastem concedes lead drug flopped in PhII mesothelioma study
Verastem concedes lead drug flopped in PhII mesothelioma study
Verastem concedes lead drug flopped in PhII mesothelioma study
Submitted by
admin
on September 28, 2015 - 8:21am
Source:
Fierce Biotech
News Tags:
Verastem
mesothelioma
Defactinib
clinical trials
Headline:
Verastem concedes lead drug flopped in PhII mesothelioma study
Do Not Allow Advertisers to Use My Personal information
